MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients - Jilg, Stefanie; Schwaab, Juliana; Sockel, Katja; Crodel, Carl C.; Brueckl, Valeska; Stegelmann, Frank; Jentzsch, Madlen; Sasca, Daniel; Moyses, Margarete; Fuhrmann, Stephan; Gundel, Daniel; Caduc, Madlen; et al. (Annals of hematology, 2024)
Online veröffentlicht: 29. Juli 2024